Ann: Dimerix Completes $20M Placement, page-123

yes understand that. I am just saying the broker would have approached these buyers telling them they were getting a great opportunity to buy in and make a good profit on the expected share price increase which they and Nina then effectively killed. If no pharma deal falls very quickly these new buyers will be looking at a loss unless they can sell before it drops under 30 cents. Lots of people here go on about what a great job Nina has done here but the reality is they stuffed up by raising before the market could revalue the phase 3 results. DXB is now 20 million richer in the bank but the market cap hasn’t changed. The longer it takes to announce the next pharma deal the more the share price will drop. Very poor decision by management.